Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99m) Tc-HMPAO.

Authors: Sole A, Spriet M, Galuppo L D, Padgett K A, Borjesson D L, Wisner E R, Brosnan R J, Vidal M A

Journal: Equine veterinary journal

DOI: 10.1111/j.2042-3306.2011.00530.x PubMed: 22212017Log in to save

Summary

# Editorial Summary Intralesional injection remains the standard method for delivering mesenchymal stem cells to equine soft tissue injuries, yet this approach carries inherent risks of iatrogenic damage and proves impractical for certain lesions that lack safe needle access. Sole and colleagues employed scintigraphic imaging with radiolabelled (99m)Tc-HMPAO to track allogeneic bone marrow-derived MSC distribution following either intra-arterial or intravenous regional limb perfusion in sound horses, comparing cellular retention and clearance patterns between these two systemic delivery routes. Both methods successfully delivered stem cells to the distal limb tissues, though intra-arterial administration demonstrated superior cell retention within target structures compared to regional IV perfusion, with sustained activity in the affected limb evident on delayed imaging. The findings suggest that intra-arterial delivery represents a viable alternative to intralesional injection, potentially allowing clinicians to treat deep or inaccessible soft tissue lesions whilst minimising procedural trauma and may warrant investigation in naturally diseased tissue to determine whether improved localisation translates to enhanced clinical outcomes.

Read the full abstract on PubMed

Practical Takeaways

•Intra-arterial and intravenous regional perfusion represent viable alternatives to intralesional MSC injection, potentially reducing iatrogenic tissue damage when direct needle access is limited or risky
•Scintigraphic imaging with radiolabeled cells can guide clinical decision-making about which delivery route optimizes cell distribution to target lesions
•These non-intralesional routes may expand MSC therapy options for distal limb injuries that are anatomically difficult to access directly

Key Findings

•Study evaluated scintigraphic tracking of mesenchymal stem cells administered via intra-arterial and intravenous regional limb perfusion routes in normal equine distal limbs
•Technetium-99m-HMPAO labeling was used to visualize and compare distribution patterns between administration routes
•Alternative delivery routes to direct intralesional injection were successfully assessed as potential methods for treating inaccessible soft tissue lesions

Conditions Studied

soft tissue injuries of the distal limblesions requiring alternative administration routes

Related References

Ultrasound-guided injection of the cranial tibial artery for stem cell administration in horses.

Torrent A, Spriet M, Espinosa-Mur P, Clark K C, Whitcomb M B, Borjesson D L, Galuppo L D(2019)Equine veterinary journal

Aspiration, but not injection, decreases cultured equine mesenchymal stromal cell viability.

Williams Lynn B, Russell Keith A, Koenig Judith B, Koch Thomas G(2016)BMC veterinary research

The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses.

MacDonald Elizabeth S, Barrett Jennifer G(2019)Frontiers in veterinary science

Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies.

Berglund A K, Schnabel L V(2017)Equine veterinary journal

Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.

Sole A, Spriet M, Padgett K A, Vaughan B, Galuppo L D, Borjesson D L, Wisner E R, Vidal M A(2013)Equine veterinary journal